Speaker

June 29, 2021    ,

Clinical trials and Clinical Research

Dattatreya Mukherjee
11:20 AM-11:45 AM webinar on Clinical Trials and Case Reports

Dattatreya Mukherjee

Jinan University, P.R China China

Title: The Hybrid Survey on the Acceptance and Affordability of COVID 19 Vaccine among the People of Konnagar- Uttarpara Belt, West Bengal, India- A Survey Based Study Abstract:

Abstract:

A Hybrid Survey on the Acceptance and Affordability of COVID 19 Vaccine among the People of Konnagar- Uttarpara Belt, West Bengal, India- A Survey Based Study

Overview: Currently, multiple vaccines for coronavirus disease 2019 (COVID-19) are in clinical trials and in the market. In Dec 2020 to Feb 2021, 1543 individuals in konnagar- Uttarpara belt, West Bengal surveyed to evaluate possible acceptance rates, affordability and factors affecting the acceptance of a vaccine for COVID-19.

Method of Study: Questionnaire is prepared, 1200 in physical format and also as the google form. The form is circulated physically and digitally among the people and then we have collected the data in excel. Based on the result we have prepared our statistical graphs.

Result 

Physical Survey [n= 1100]: 94.4 percent of respondents reported that they would be very or very likely to take a vaccine for COVID-19, 4.8 percent don’t want to take vaccine and 0.8 don’t know about their decision. In that 91.2 percent respondents want to take Indian Vaccine; 2.2 percent respondents want to take foreign vaccine. Other respondents can take any vaccine. The affordability, majority needs a vaccine which cost less than 500 INR and it should be regulated by government.

Digital Survey [n=443]: Result 94.1 percent of respondents reported that they would be very or very likely to take a vaccine for COVID-19, 5.19 percent don’t want to take vaccine and 0.71 don’t know about their decision. In that 85 percent respondents want to take Indian Vaccine; 3.6 percent respondents want to take foreign vaccine. Other respondents can take any vaccine The affordability, majority needs a vaccine which cost less than 500 INR and it should be regulated by government.

Conclusion: Majority of Responders want a COVID 19 vaccine. Majority responders want Indian COVID19 Vaccine. Majority responders want a vaccine in a cost of below 500 INR

Biography:

Dattatreya Mukherjee, he studied  MBBS and worked as Research Assistant and Undergraduate research scholar
at Jinan University which is located at  P.R China.